CURE’s Chronic Lymphocytic Leukemia (CLL) page features the latest cancer news and updates on CLL Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in chronic lymphocytic leukemia.

Latest News

doctor holding pill bottle
Brukinsa Lengthens Time to Progression in Relapsed/Refractory CLL, SLL

December 10th 2023

Brukinsa led to improved progression-free survival over Imbruvica in patients with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma, follow-up from the phase 3 ALPINE study showed.

Imbruvica-Venclexta Combination Demonstrates Benefits in Untreated CLL

December 4th 2023

FDA approval: developing story
FDA Approves Jaypirca for Pretreated CLL, SLL

December 2nd 2023

FDA on blue background
FDA Accepts Priority Review for Breyanzi in CLL

November 17th 2023

image of CLL
CLL and Its Treatment Can Heighten Patients’ Risk of Infections

November 8th 2023